NDC 0597-0164-90
Glyxambi 25 mg/1
empagliflozin and linagliptin · TABLET, FILM COATED
Glyxambi is a tablet, film coated containing empagliflozin and linagliptin at a strength of 25 mg/1. Manufactured by Boehringer Ingelheim Pharmaceuticals, Inc..
Key Facts
- Brand Name
- Glyxambi
- Generic Name
- empagliflozin and linagliptin
- NDC Code (Package)
0597-0164-90- NDC Code (Product)
0597-0164- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Strength
- 25 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA206073
- Drug Class
- Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitor [EPC]
- Marketing Start
- 01/30/2015
Recall History
No Recall HistoryView Full Drug Page
Glyxambi — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.